Free Trial

Oncotelic Therapeutics (OTLC) Short Interest Ratio & Short Volume

Oncotelic Therapeutics logo
$0.05 0.00 (-7.60%)
As of 04/30/2025 03:50 PM Eastern

Oncotelic Therapeutics Short Interest Data

Oncotelic Therapeutics (OTLC) has a short interest of 62,800 shares, representing 0.03% of the float (the number of shares available for trading by the public). This marks a 307.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 138,221 shares to cover all short positions.

Current Short Interest
62,800 shares
Previous Short Interest
15,400 shares
Change Vs. Previous Month
+307.79%
Dollar Volume Sold Short
$3,234.20
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
407,273,000 shares
Short Percent of Float
0.03%
Today's Trading Volume
173,627 shares
Average Trading Volume
138,221 shares
Today's Volume Vs. Average
126%
Short Selling Oncotelic Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Oncotelic Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OTLC Short Interest Over Time

OTLC Days to Cover Over Time

OTLC Percentage of Float Shorted Over Time

Oncotelic Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202562,800 shares $3,234.20 +307.8%0.0%0.2 $0.05
3/31/202515,400 shares $1,001.00 -44.0%0.0%0.1 $0.07
3/15/202527,500 shares $1,281.50 -57.0%0.0%0.1 $0.05
2/28/202563,900 shares $2,524.05 +15,875.0%0.0%0.4 $0.04
2/15/2025400 shares $15.96 -77.8%0.0%0 $0.04
1/31/20251,800 shares $54.54 +350.0%N/A0 $0.03
1/15/2025400 shares $13.76 -95.4%N/A0 $0.03
12/31/20248,600 shares $301.00 +230.8%N/A0 $0.04
12/15/20242,600 shares $78.00 +18.2%N/A0 $0.03
11/30/20242,200 shares $70.18 -94.9%N/A0 $0.03
11/15/202443,400 shares $1,297.66 +137.2%N/A0.1 $0.03
10/31/202418,300 shares $590.18 -62.1%N/A0 $0.03
10/15/202448,300 shares $1,724.31 +11,975.0%N/A0 $0.04
9/30/2024400 shares $8.40 -80.0%N/A0 $0.02
9/15/20242,000 shares $42.40 -59.2%N/A0 $0.02
8/31/20244,900 shares $111.23 +1,125.0%N/A0 $0.02
8/15/2024400 shares $8.24 No ChangeN/A0 $0.02
7/31/2024400 shares $11.20 -98.2%N/A0 $0.03
7/15/202422,000 shares $572.00 +266.7%N/A0.1 $0.03
6/30/20246,000 shares $195.00 +1,400.0%N/A0 $0.03
6/15/2024400 shares $15.72 -83.3%N/A0 $0.04
5/31/20242,400 shares $89.04 +500.0%N/A0 $0.04
5/15/2024400 shares $14.40 -77.8%N/A0 $0.04
4/30/20241,800 shares $71.91 -84.2%N/A0 $0.04
4/15/202411,400 shares $468.54 +2,750.0%N/A0.1 $0.04
3/31/2024400 shares $14.39 -89.7%N/A0 $0.04
3/15/20243,900 shares $144.69 -75.2%N/A0.1 $0.04
2/29/202415,700 shares $554.21 -90.9%N/A0.1 $0.04
2/15/2024172,400 shares $6,637.40 +34.8%N/A0.9 $0.04
1/15/2024111,900 shares $4,420.05 +27,875.0%N/A1.2 $0.04
12/31/2023400 shares $15.30 No ChangeN/A0 $0.04
12/15/2023400 shares $15.76 No ChangeN/A0 $0.04
11/30/2023400 shares $16.28 -97.6%N/A0 $0.04
11/15/202316,700 shares $542.75 -58.2%N/A0 $0.03
10/31/202339,900 shares $1,312.71 +66.3%N/A0.1 $0.03
10/15/202324,000 shares $816.00 +1,400.0%N/A0.1 $0.03
9/30/20231,600 shares $49.60 -95.4%N/A0 $0.03
9/15/202334,500 shares $1,086.75 -52.7%N/A0.1 $0.03
8/31/202372,900 shares $1,909.98 +138.2%N/A0.2 $0.03
8/15/202330,600 shares $703.80 -4.7%N/A0.3 $0.02
The collapse has already started (Ad)

The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts.

Watch the 2025 Trade War dividend protection briefing now
7/31/202332,100 shares $767.19 -50.3%N/A0.1 $0.02
7/15/202364,600 shares $1,627.92 +12.0%N/A0.1 $0.03
6/30/202357,700 shares $1,442.50 +1,054.0%N/A0 $0.03
6/15/20235,000 shares $150.00 -79.8%N/A0 $0.03
5/31/202324,700 shares $768.17 +6,075.0%N/A0.1 $0.03
5/15/2023400 shares $14.76 -55.6%N/A0 $0.04
4/30/2023900 shares $37.80 +125.0%N/A0 $0.04
4/15/2023400 shares $20.40 -99.1%N/A0 $0.05
3/31/202342,900 shares $2,037.75 +164.8%N/A0.3 $0.05
3/15/202316,200 shares $920.16 No ChangeN/A0.1 $0.06
2/28/202316,200 shares $891.00 -57.7%N/A0.1 $0.06
2/15/202338,300 shares $2,106.50 +137.9%N/A0.1 $0.06
1/31/202316,100 shares $821.10 -68.2%N/A0.1 $0.05
1/15/202350,700 shares $2,940.60 +53.6%N/A0.2 $0.06
12/30/202233,000 shares $1,485.00 +11.9%N/A0.1 $0.05
12/15/202229,500 shares $1,416.00 +2,358.3%N/A0.1 $0.05
11/30/20221,200 shares $70.32 -86.8%N/A0 $0.06
11/15/20229,100 shares $682.50 -65.5%N/A0.1 $0.08
10/31/202226,400 shares $1,188.00 -58.8%N/A0 $0.05
10/15/202264,000 shares $3,744.00 -49.7%N/A0.2 $0.06
9/30/2022127,200 shares $8,522.40 +4,286.2%N/A0.3 $0.07
9/15/20222,900 shares $205.90 -62.8%N/A0 $0.07
8/31/20227,800 shares $630.24 -77.5%N/A0 $0.08
8/15/202234,600 shares $2,899.48 -51.1%N/A0.1 $0.08
7/31/202270,700 shares $7,777.00 +288.5%N/A0.2 $0.11
7/15/202218,200 shares $1,820.00 -33.3%N/A0 $0.10
6/30/202227,300 shares $4,641.00 +320.0%N/A0 $0.17
6/15/20226,500 shares $812.50 +14.0%N/A0 $0.13
5/31/20225,700 shares $1,227.21 +119.2%N/A0 $0.22
5/15/20222,600 shares $507.00 -69.8%N/A0 $0.20
4/30/20228,600 shares $1,857.60 +65.4%N/A0 $0.22
4/15/20225,200 shares $1,196.78 +13.0%N/A0 $0.23
3/31/20224,600 shares $1,054.78 -41.0%N/A0 $0.23
3/15/20227,800 shares $1,704.30 -71.6%N/A0 $0.22
2/28/202227,500 shares $6,817.25 +97.8%N/A0.1 $0.25
2/15/202213,900 shares $2,780.00 +157.4%N/A0.1 $0.20
1/31/20225,400 shares $864.00 +1,250.0%N/A0 $0.16
1/15/2022400 shares $70.50 -95.1%N/A0 $0.18
12/31/20218,100 shares $1,359.18 -30.2%N/A0 $0.17
12/15/202111,600 shares $1,914.00 -80.3%N/A0 $0.17
11/30/202158,800 shares $7,938.00 +429.7%N/A0.1 $0.14
11/15/202111,100 shares $1,276.50 -74.5%N/A0 $0.12
10/29/202143,500 shares $5,659.35 +42.6%N/A0.2 $0.13
10/15/202130,500 shares $3,583.75 +682.1%N/A0.1 $0.12
9/30/20213,900 shares $565.50 -51.3%N/A0 $0.15
9/15/20218,000 shares $1,050.40 +90.5%N/A0 $0.13
8/31/20214,200 shares $579.60 +2.4%N/A0 $0.14
8/13/20214,100 shares $512.50 -86.2%N/A0 $0.13
7/30/202129,800 shares $4,619.00 +684.2%N/A0.1 $0.16
7/15/20213,800 shares $672.60 -83.0%N/A0 $0.18
The collapse has already started (Ad)

The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts.

Watch the 2025 Trade War dividend protection briefing now
6/30/202122,300 shares $0.00 +214.1%N/A0.1 $0.00

OTLC Short Interest - Frequently Asked Questions

What is Oncotelic Therapeutics' current short interest?

Short interest is the volume of Oncotelic Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 62,800 shares of OTLC short. 0.03% of Oncotelic Therapeutics' shares are currently sold short. Learn More on Oncotelic Therapeutics' current short interest.

What is a good short interest percentage for Oncotelic Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of Oncotelic Therapeutics' floating shares are currently sold short.

Is Oncotelic Therapeutics' short interest increasing or decreasing?

Oncotelic Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 62,800 shares, an increase of 307.8% from the previous total of 15,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Oncotelic Therapeutics' short interest compare to its competitors?

0.03% of Oncotelic Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oncotelic Therapeutics: XBiotech Inc. (3.58%), Galectin Therapeutics Inc. (19.17%), Context Therapeutics Inc. (4.49%), Ventyx Biosciences, Inc. (11.46%), Black Diamond Therapeutics, Inc. (18.69%), InflaRx (1.64%), Elutia Inc. (0.34%), Cardiol Therapeutics Inc. (2.59%), Vigil Neuroscience, Inc. (1.87%), Anixa Biosciences, Inc. (1.21%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Oncotelic Therapeutics stock?

Short selling OTLC is an investing strategy that aims to generate trading profit from Oncotelic Therapeutics as its price is falling. OTLC shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncotelic Therapeutics?

A short squeeze for Oncotelic Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLC, which in turn drives the price of the stock up even further.

How often is Oncotelic Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLC, twice per month. The most recent reporting period available is April, 15 2025.




This page (OTCMKTS:OTLC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners